| Financial Year |
March 31 2023 |
| Monetary Funds |
4,861,784,839.38 |
| Held-for-trading Financial Assets |
1,036,330,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,334,632,292.24 |
| Advances to Suppliers |
682,671,414.60 |
| Other Receivables |
201,806,971.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
378,624,983.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
51,055,402.72 |
| Total Current Assets |
8,546,905,904.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
438,035,058.11 |
| Investment Properties |
275,029,627.35 |
| Fixed Assetes |
2,955,435,545.40 |
| Under-construction Projects |
97,184,295.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,869,483,651.49 |
| R&D expenses |
114,574,167.99 |
| Goodwill |
6,058,573,813.55 |
| Long-Term Deferred and Prepaid Expenses |
349,798,565.85 |
| Deferred Income Tax Assets |
284,349,647.28 |
| Other Non-Current Assets |
1,322,674,133.47 |
| Sub-Total of Non-Current Assets |
16,873,723,334.85 |
| Total Assets |
25,420,629,239.31 |
| Short-Term Loans |
612,005,113.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,797,872.97 |
| Accounts Payable |
958,107,500.20 |
| Accounts Received In Advance |
18,155,115.51 |
| Employee Compensation Payable |
409,832,750.68 |
| Taxes Payable |
166,850,754.45 |
| Interest Payable |
20,572,360.26 |
| Dividend Payable |
-- |
| Other payables |
685,720,033.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
63,283,861.41 |
| Other Current Liabilities |
15,816,641.80 |
| Sub-Total of Current Liabilities |
6,062,515,585.59 |
| Long-term Loans |
177,974,095.60 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
24,373,121.16 |
| Special Payable |
-- |
| Estimatied Liabilities |
14,974,849.92 |
| Deferred Income Tax Liabilities |
362,247,742.89 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,090,495,742.40 |
| Total Liabilities |
7,153,011,327.99 |
| Paid-In Capital(Or Share Stock) |
1,346,132,221.00 |
| Capital Surplus |
8,995,632,763.28 |
| Surplus Reserve |
494,487,333.38 |
| LESS:Treasury Stock |
69,612,423.00 |
| Undistributed Profits |
6,057,768,239.60 |
| Minority Stockholder's Interest |
1,261,915,789.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,005,702,122.30 |
| Owner's Equity（Stockholder's Equity） |
18,267,617,911.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
25,420,629,239.31 |
